BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM. Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev 2022;138:104689. [PMID: 35588933 DOI: 10.1016/j.neubiorev.2022.104689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Burmester DR, Madsen MK, Szabo A, Aripaka SS, Stenbæk DS, Frokjaer VG, Elfving B, Mikkelsen JD, Knudsen GM, Fisher PM. Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation. Compr Psychoneuroendocrinol 2023;13:100163. [PMID: 36545240 DOI: 10.1016/j.cpnec.2022.100163] [Reference Citation Analysis]
2 Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S, Mørup M, Ganz M, Knudsen GM, Fisher PM. Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects. Neuroimage 2022;264:119716. [PMID: 36341951 DOI: 10.1016/j.neuroimage.2022.119716] [Reference Citation Analysis]
3 Bedford P, Hauke DJ, Wang Z, Roth V, Nagy-huber M, Holze F, Ley L, Vizeli P, Liechti ME, Borgwardt S, Müller F, Diaconescu AO. The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity.. [DOI: 10.1101/2022.11.01.514687] [Reference Citation Analysis]
4 Mallaroni P, Mason NL, Kloft L, Reckweg JT, van Oorsouw K, Toennes SW, Tolle HM, Amico E, Ramaekers JG. Ritualistic use of ayahuasca enhances a shared functional connectome identity with others.. [DOI: 10.1101/2022.10.07.511268] [Reference Citation Analysis]
5 Drew L. Your brain on psychedelics. Nature 2022;609:S92-4. [PMID: 36171369 DOI: 10.1038/d41586-022-02874-7] [Reference Citation Analysis]
6 Barrett FS. Comparative Pharmacology and Circuit-Level Models of the Effects of Psychedelic Drugs on the Human Brain. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2022;7:849-851. [DOI: 10.1016/j.bpsc.2022.07.005] [Reference Citation Analysis]
7 Kuburi S, Di Passa A, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review. Chronic Stress 2022;6:247054702211153. [DOI: 10.1177/24705470221115342] [Reference Citation Analysis]